Head-to-Head
Isagenix vs Optavia
Isagenix takes the edge with the better balance of signals.
51
Momentum
41
#20
Rank
#30
+4%
30-Day
0%
-14%
90-Day
-15%
1
Streak (weeks)
1
Isagenix — the case
"Anti-Ozempic crowd is a real market now."
Growth
- • GLP-1 backlash sending people back to shakes
Risk
- • Aging rep force
Optavia — the case
"Fighting pharmaceuticals with shakes. Hard mode."
Growth
- • New maintenance plans
- • Coach-led model still works
Risk
- • Ozempic class is existential
- • Public stock cratered